ArticleFrontiers in microbiology2026
A hospital-based genomic analysis reveals predominance of ST215
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Tuberculosis (TB) remains a major public health challenge in Northwest China. Genomic approaches provide valuable tools for characterizing the population structure, transmission patterns, and drug-resistance profiles of Methods: This single-center, hospital-based study analyzed 26 clinical MTB isolates collected from a tertiary hospital in Northwest China. Whole-genome sequencing (WGS), drug susceptibility testing (DST), phylogenetic analysis, and a murine infection model were used to investigate lineage distribution, genetic relatedness, drug-resistance characteristics, and pathogenicity. Results: The Beijing lineage, represented by spoligotype SIT1, accounted for 73.08% of the isolates, and 80.77% belonged to sequence type ST215. Phylogenetic analysis identified a closely related cluster of ST215 isolates with low pairwise SNP distances, suggesting potential recent transmission within the studied cohort. No multidrug-resistant (MDR) or extensively drug-resistant (XDR) isolates were detected, and resistance was limited to sporadic monoresistance. All isolates carried the aac(2')-Ic and erm(37) genes, although these genes were not consistently associated with phenotypic resistance. In an intravenous mouse infection model, histopathological changes induced by a representative ST215 isolate were broadly comparable to those caused by the reference strain H37Rv. Discussion: This hospital-based genomic investigation identified a predominant ST215 MTB population with generally low levels of drug resistance in the studied cohort. These findings provide preliminary genomic and phenotypic evidence for MTB isolates in this specific clinical setting and highlight the need for larger, multicenter studies to further evaluate transmission patterns and drug-resistance dynamics in Northwest China.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.